StockData
FibroBiologics, Inc. logo

FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.84−0.06 (-6.72%)

Close on Nov 18, 2026Market cap $5.59MP/E –Yield –

FibroBiologics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

FibroBiologics's shares outstanding was 6M at Jun 30, 2026. For fiscal 2025 it was 2M, up 35.8% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252M+35.8%
FY2024Dec 31, 20242M+16.5%
FY2023Dec 31, 20231M0.0%
FY2022Dec 31, 20221M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20266M+224.7%
Q1 FY2026Mar 31, 20264M+105.8%
Q4 FY2025Dec 31, 20253M+76.3%
Q3 FY2025Sep 30, 20252M+28.5%
Q2 FY2025Jun 30, 20252M+18.1%
Q1 FY2025Mar 31, 20252M+17.8%
Q4 FY2024Dec 31, 20242M+20.9%
Q3 FY2024Sep 30, 20242M+18.7%
Q2 FY2024Jun 30, 20242M+15.9%
Q1 FY2024Mar 31, 20242M+10.3%
Q4 FY2023Dec 31, 20231M–
Q3 FY2023Sep 30, 20231M–
Q2 FY2023Jun 30, 20231M–
Q1 FY2023Mar 31, 20231M–

More FibroBiologics figures

See a number that looks wrong?